Antiretroviral basics
Miller, N.
Midwifery Today with International Midwife 2005(73): 30-34
2005
ISSN/ISBN: 1551-8892 PMID: 15835846 Document Number: 587053
Document emailed within 1 workday
Related Documents
Gibson, B.; McLeod, D. 1983: Non-produced means of production in Sraffa's system: basics, non-basics and quasi-basics Cambridge Journal of Economics 7(2): 141-150Gibson, B.; McLeod, D. 1983: Non-produced means of production in Sraffa's system: basics, non-basics and quasi-basics Cambridge Journal of Economics 7(2): 141-150
Gibson, B.; McLeod, D. 1983: Non-produced means of production in Sraffa's system: basics, non-basics and quasi-basics Cambridge Journal of Economics 7(2): 141-150
Gibson, B.; McLeod, D. 1983: Non-produced means of production in Sraffa's system: basics, non-basics and quasi-basics Cambridge Journal of Economics 7(2): 141-150
Jordan, L.E. 1983: Back to the basics--but the basics must include science Nursing Outlook 31(4): 207 237
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Baesi, K.; Ravanshad, M.; Ghanbarisafari, M.; Saberfar, E.; Seyedalinaghi, S.; Volk, J.E. 2014: Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran Journal of Medical Virology 86(7): 1093-1098
Thuret, I. 2004: Infection à VIH de l'enfant : quand débuter le traitement antirétroviral ? - When to initiate antiretroviral therapy in HIV-infected children? Archives de Pediatrie (Paris) 11(12): 1521-1524
Boulle, A.; Orrel, C.; Kaplan, R.; Van Cutsem, G.; McNally, M.; Hilderbrand, K.; Myer, L.; Egger, M.; Coetzee, D.; Maartens, G.; Wood, R. 2007: Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort Antiviral therapy 12(5): 753-760
Diouf, A.; Youbong, T.J.; Maynart, M.; Ndoye, M.; Diéye, F.L.; Ndiaye, N.A.; Koita-Fall, M.B.; Ndiaye, B.; Seydi, M. 2017: Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription Revue d'Epidemiologie et de Sante Publique 65(4): 295-300
Corzillius, M.; Mühlberger, N.; Sroczynski, G.; Jaeger, H.; Wasem, J.ür.; Siebert, U. 2004: Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV Antiviral Therapy 9(1): 27-36
Humphreys, E.H.; Chang, L.W.; Harris, J. 2010: Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Cochrane Database of Systematic Reviews 6: Cd006517
Rajesh, L.; Karunaianantham, R.; Narayanan, P.R.; Swaminathan, S. 2009: Antiretroviral drug-resistant mutations at baseline and at time of failure of antiretroviral therapy in HIV type 1-coinfected TB patients Aids Research and Human Retroviruses 25(11): 1179-1185
Henriksen, M. 2012: Bed bug basics Provider 38(10): 73
Hamers, R.L.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Conradie, F.; Botes, M.E.; Wellington, M.; Osibogun, A.; Sigaloff, K.C.E.; Nankya, I.; Schuurman, R.; Wit, F.W.; Stevens, W.S.; van Vugt, Mèle.; de Wit, T.F.Rinke.; Mandaliya, K.; Abdallah, S.; Jao, I.; Dolan, M.; Schuurman, R.; Wensing, A.M.; Hamers, R.L.; Sigaloff, K.C.E.; Straatsma, E.; Wit, F.W.; van Vugt, M.; Lange, J.M.; Rinke de Wit, T.F.; Osibogun, A.; Akanmu, S.; Botes, M.E.; Conradie, F.; Ive, P.; Sanne, I.; Wallis, C.L.; Letsoalo, E.; Stevens, W.S.; Hardman, M.; Kityo, C.; Namayanja, G.; Nakatudde, L.; Nankya, I.; Kiconco, M.; Abwola, M.; Mugyenyi, P.; Ndembi, N.; Lyagoba, F.; Kaleebu 2011: HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study Lancet. Infectious Diseases 11(10): 750-759
Tan, R.; Westfall, A.O.; Willig, J.H.; Mugavero, M.J.; Saag, M.S.; Kaslow, R.A.; Kempf, M.C. 2008: Clinical outcome of HIV-infected antiretroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 47(5): 553-558
Lailulo, Y.; Kitenge, M.; Jaffer, S.; Aluko, O.; Nyasulu, P.S. 2020: Factors associated with antiretroviral treatment failure among people living with HIV on antiretroviral therapy in resource-poor settings: a systematic review and metaanalysis Systematic Reviews 9(1): 292
Green, C.R. 1988: Getting back to basics: the three Rs American Pharmacy 28(6): 31-33
Streger, M.R. 2003: Back to basics. What I'd like to see Emergency Medical Services 32(11): 38
Wendo, C. 2003: Africans advocate antiretroviral strategy similar to DOTS. AIDS experts suggest community health workers should help in the delivery of antiretroviral drugs Lancet 362(9391): 1210